Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-FR Version v4-FR
Language French French
Date Updated 2019-12-10 2019-10-21
Drug Identification Number 02426935 02426935
Brand name MED-LATANOPROST MED-LATANOPROST
Common or Proper name Latanoprost Latanoprost
Company Name GENERIC MEDICAL PARTNERS INC GENERIC MEDICAL PARTNERS INC
Ingredients LATANOPROST LATANOPROST
Strength(s) 50MCG 50MCG
Dosage form(s) SOLUTION SOLUTION
Route of administration OPHTHALMIC OPHTHALMIC
Packaging size 1 bottle 1 bottle
ATC code S01EE S01EE
ATC description ANTIGLAUCOMA PREPARATIONS AND MIOTICS ANTIGLAUCOMA PREPARATIONS AND MIOTICS
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date 2019-07-15 2019-07-15
Actual start date 2019-07-15 2019-07-15
Estimated end date 2019-11-30 2019-11-30
Actual end date 2019-12-02
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Shortage over. Alternative supplier arranged for all contracted business, commenced 24 July, for duration of expected shortage. Alternative supplier will continue to support contracted business for the duration of the shortage.
Health Canada comments